Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losmapimod in COPD Exacerbations
NCT02299375Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of losmapimod in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Dec 2014; status: completed.
02
Drugs
losmapimod
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02299375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02299375.